Company intelligence / Profile preview

Genetalks

Ownership: Private
Development stage: Commercial

Overview

Genetalks provides innovative genetic health solutions based on advanced genetics, including cancer liquid biopsies. The company leverages cutting-edge genomic technologies to deliver diagnostics and personalized healthcare services[1].

Therapeutic areas: OncologyOther
Modalities: Liquid biopsyGenetic testingDiagnostics (based on genetic science)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Genetalks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genetalks.

Explore the full profile